China Resources Boya Bio-pharmaceutical Group (SHE:300294) obtained approval from health authorities in the Chinese autonomous region of Inner Mongolia to establish a blood collection station, according to a Shenzhen Stock Exchange filing on Monday.
The Chinese drugmaker will set up the station in Dalate Banner, Ordos City, China, the filing said.